期刊文献+

连续性血液净化在ICU的应用研究进展 被引量:6

下载PDF
导出
摘要 连续性血液净化(continuousbloodpurification,CBP)是由间隙性血液透析逐步发展而来的,应用范围不仅包括最早的重症急性肾衰竭,而且包含了各种临床危重症的救治。由于其血流动力学稳定、溶质清除率高、清除炎陛介质”、生物相容性好、提供充分营养支持和维持水、电解质平衡的特点,已经在ICU中得到越来越广泛的应用,下面就CBP在ICU中的应用做一综述。
作者 陈世明 高清
出处 《中国急救复苏与灾害医学杂志》 2013年第6期563-563,577,共2页 China Journal of Emergency Resuscitation and Disaster Medicine
  • 相关文献

参考文献15

  • 1郑建鹏,茅尧生,曹淼英.连续性血液净化对严重脓毒症患者Toll样受体及炎症介质的影响[J].中国急救复苏与灾害医学杂志,2010(4):331-334. 被引量:7
  • 2Roneo C, Benomo R. Int J Artif Organs, 2002, 25: 331-334.
  • 3Swanz RD, Bustarlli RT, et al. Clin Nephrol, 2005, 63: 335-345.
  • 4Gettings LG, Reynolds HN, et al. Outcome in post-traumatic acute renal replacement therapy is apphed early vs. late.Intensive Care Med, 1999, 25 (8): 805-813.
  • 5Elahi M, Lira MY, Joseph RN, et al. Early hermof]Jtmtion improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg, 2004, 26(5): 1027-1031.
  • 6Maccariello E, Soares M, Valente C, et al. RIFLE classification in patients with acute kidney injury in need of renal replacemernt therapy. Intensive Care Med, 2007, 33(4): 597-605.
  • 7中华人民共和国卫生部.血液净化标准操作规程.2010-01.
  • 8吕方,方卢刚,彭守春等.血液净化治疗百草枯中毒的回顾性分析.中国急救复苏与灾害杂志,2010,12(5):1131-1133.
  • 9Jonnes-Boyao, Rapaport S, Bazin R et al. ASAIO J, 2004, 50: 102-109.
  • 10Chertow GM, Soroko SH, Paganini EP, et al. Kidney Int, 2006, 70: 1120-1126.

二级参考文献51

共引文献105

同被引文献49

  • 1邹协群,金平,李良海.床旁血液灌流联合血液透析治疗重症中毒患者疗效评价[J].今日健康,2016,15(3):102-102. 被引量:3
  • 2林浙兵,吴碎秋,朱铮铮.重症脓毒血症患者连续血液净化治疗与护理[J].中华临床感染病杂志,2013,6(5):304-306. 被引量:13
  • 3贾利宁,桂保松.枸橼酸钠抗凝在血液净化中的应用进展[J].国际移植与血液净化杂志,2006,4(4):7-10. 被引量:16
  • 4Oppert M, Engel C, Brunkhorst FM, et al. Acute renal failure in patients with severe sepsis and septic shock-a significant independent risk factor for motality: result from the German prevalence study [J]. Nephrol Dial Transplant, 2008,23 (3) : 904-909.
  • 5Ronco C, Levin A, Warnoek DG, et al. Improving out- comes from acute kidney injury (AKI) :Report on an ini tiative[J]. J Artif Organs, 2007,30 (5) : 373-376.
  • 6Yah SB, Helterbrand JD, Hartman DI., et al. Low level of protein C are associated with poor outcome in severe sep sis[J]. Chest,2001,120(3) :915-922.
  • 7Levi M. Disseminate dintrav ascular coagulation[J]. Crit Care Med,2007,35(9) :2191-2195.
  • 8Evenepoel P, Dejagere T, Verhamme P, et al. Heparin coated polyacrylonitrile membrane versus regional citrate anticoagulation:a prospective randomized study of 2 anti- coagulation strategies in patients at risk of bleeding[J]. Am J Kidney Dis,2007,49(5) :642-649.
  • 9Bos JC, Grooteman MP, van Houte AJ, et al. Low poly- morphonuclear cell degranulation during citrate anticoag ulation:a comparison between citrate and heparin dialysis [J]. Nephrol Dial Transplant, 1997,12(7) : 1397-1393.
  • 10Dhondt A, Vanholder R, Tielemans C, et al. Effect of re- gional citrate anticoagulation on leucopenia, complement activation,and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes [J]. Nephron,2000,85(4) :334 342.

引证文献6

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部